Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · IEX Real-Time Price · USD
1.03
+0.02 (1.98%)
At close: Aug 12, 2022 4:00 PM
1.02
-0.01 (-0.97%)
After-hours: Aug 12, 2022 7:35 PM EDT

Cash Flow Statement (Trailing)

Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Quarter Ending 2022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302019-04-30
Net Income
-12.36-9.75-8.3-6.05-5.05-5.05---4.41-4.86
Depreciation & Amortization
000000--00
Share-Based Compensation
4.413.452.892.272.031.87--1.80.4
Other Operating Activities
1.34-0.010.070.050.31.52000.263.42
Operating Cash Flow
-6.61-6.31-5.33-3.73-2.71-1.65---2.35-1.05
Capital Expenditures
-0.1100000--00
Acquisitions
00000.10.1--0.110.23
Investing Cash Flow
-0.110000.10.1--0.110.23
Share Issuance / Repurchase
18.9117.0117.0117.112.20.11--2.310.24
Debt Issued / Paid
-0.061.051.892.172.251.19---0.020.07
Financing Cash Flow
18.8518.0618.919.284.451.3--2.290.31
Net Cash Flow
12.1311.7513.5715.561.84-0.25--0.05-0.5
Free Cash Flow
-6.72-6.31-5.33-3.73-2.71-1.65---2.35-1.05
Free Cash Flow Per Share
-0.07-0.07-0.06-0.04-0.04-0.02---0.03-0.02
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).